Anzeige
Mehr »
Login
Mittwoch, 08.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Diese Aktie hebt ab: +130,67% Kursgewinn in 1 Monat – das sind die Gründe
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0DN17 | ISIN: US74112D1019 | Ticker-Symbol: PBV
Frankfurt
07.05.24
15:57 Uhr
64,00 Euro
-0,50
-0,78 %
1-Jahres-Chart
PRESTIGE CONSUMER HEALTHCARE INC Chart 1 Jahr
5-Tage-Chart
PRESTIGE CONSUMER HEALTHCARE INC 5-Tage-Chart
RealtimeGeldBriefZeit
64,0066,5007.05.

Aktuelle News zur PRESTIGE CONSUMER HEALTHCARE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
25.04.Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Fourth Quarter and Year-End Earnings Results1
19.04.Here's Why You Should Retain Prestige Consumer (PBH) Stock Now1
03.04.Prestige Consumer Healthcare Inc.: Dramamine® Celebrates its 75th Anniversary by Reviving an Unexpected Partner: The Barf Bag1
02.04.Prestige Consumer (PBH) Banks on its Portfolio Amid Cost Woes1
18.03.Prestige Consumer HC, Rush Street Interactive, and Zeta - added to Oppenheimer's Trifecta list2
05.03.Reasons to Retain Prestige Consumer (PBH) Stock for Now1
09.02.Prestige Consumer (PBH) Q3 Earnings Top, Gross Margin Expands-
08.02.Earnings call: Prestige Consumer Healthcare posts solid Q3 growth-
08.02.Prestige Consumer Healthcare Inc reports results for the quarter ended in December - Earnings Summary-
08.02.Prestige Consumer Healthcare Inc. - 10-Q, Quarterly Report-
08.02.Prestige Consumer Healthcare Inc. Reports Third Quarter Fiscal 2024 Results198Revenue of $282.7 Million in Q3, Up 2.6% Versus Prior YearDiluted EPS of $1.06 in Q3, Up 2.2% Versus Prior YearReduced Leverage Ratio to 2.9x at Quarter EndRaising Full-Year Fiscal 2024 Earnings Outlook...
► Artikel lesen
08.02.Prestige Consumer Healthcare Inc. - 8-K, Current Report-
08.02.Prestige Consumer Healthcare GAAP EPS of $1.06 beats by $0.02, revenue of $282.7M beats by $2.34M-
07.02.Prestige Consumer Healthcare Q3 2024 Earnings Preview-
02.02.Prestige Consumer Healthcare Inc.: Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING 1% Tolnaftate Athlete's Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene216TARRYTOWN, N.Y., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company ("Insight"), is voluntarily recalling two lots of TING® 1% Tolnaftate Athlete's...
► Artikel lesen
10.01.Prestige Consumer Healthcare Inc. to Release Fiscal 2024 Third Quarter Earnings Results1
28.12.23Reasons to Buy Prestige Consumer (PBH) Stock for Now2
22.12.23Prestige Consumer Healthcare Inc.: Insight Pharmaceuticals Issues Voluntary Nationwide Recall of Americaine 20% Benzocaine Topical Anesthetic Spray Due to the Presence of Benzene258TARRYTOWN, N.Y., Dec. 22, 2023 (GLOBE NEWSWIRE) -- Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company ("Insight"), is voluntarily recalling one lot of Americaine® 20% Benzocaine...
► Artikel lesen
13.12.23Prestige Consumer Healthcare Inc. - 8-K, Current Report1
29.11.23Should You Invest in Prestige Consumer Healthcare (PBH)?2
Seite:  Weiter >>
24 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1